<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药融圈 | wechat-feeds</title><link>http://MzUyNTgyNjUzMw.favicon.privacyhide.com/favicon.ico</link><description>药融圈PHARNEX汇聚数万医药大咖，得到数千家医药创业者鼎力支持，开展日常专题讲座。致力于成为“专业、前沿、权威、严谨”的医药行业资讯平台，以及项目、技术、工厂、融资、股权投资等资源整合平台。欢迎您关注药融圈，共同碰撞“药”的火花!</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 26 May 2021 12:18:25 +0800</pubDate><image><url>http://MzUyNTgyNjUzMw.favicon.privacyhide.com/favicon.ico</url><title>药融圈 | wechat-feeds</title><link>http://MzUyNTgyNjUzMw.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>全球疫苗竞赛烽烟四起，新锐丽珠新冠疫苗临床进展显著</title><link>https://mp.weixin.qq.com/s/sgeI-QSTipvmpfh4-0l_ww</link><description></description><content:encoded><![CDATA[全球疫苗竞赛烽烟四起，新锐丽珠新冠疫苗临床进展显著]]></content:encoded><pubDate>Tue, 25 May 2021 17:30:37 +0800</pubDate></item><item><title>首届基石药业肿瘤精准治疗论坛  权威专家共议肿瘤精准治疗创新</title><link>https://mp.weixin.qq.com/s/zWfFysKhPicPmUPD2Mulfg</link><description></description><content:encoded><![CDATA[首届基石药业肿瘤精准治疗论坛  权威专家共议肿瘤精准治疗创新]]></content:encoded><pubDate>Tue, 25 May 2021 17:30:37 +0800</pubDate></item><item><title>“酶”好时代来临：数家药企角逐助力绿色制药</title><link>https://mp.weixin.qq.com/s/I1ylNU4bi0yLS3nGFcDn3A</link><description></description><content:encoded><![CDATA[“酶”好时代来临：数家药企角逐助力绿色制药]]></content:encoded><pubDate>Tue, 25 May 2021 17:30:37 +0800</pubDate></item><item><title>四川协力制药-特色原料药CDMO企业，邀您参加第三届CMC-China大会</title><link>https://mp.weixin.qq.com/s/Jm9BWfmfjj3NSGvvxyr-WQ</link><description></description><content:encoded><![CDATA[四川协力制药-特色原料药CDMO企业，邀您参加第三届CMC-China大会]]></content:encoded><pubDate>Tue, 25 May 2021 17:30:37 +0800</pubDate></item><item><title>十余位原FDA/CDE/千人共话创新制剂及改良型新药峰会</title><link>https://mp.weixin.qq.com/s/n0P0eGIVtJZbMGM1iY_TmA</link><description></description><content:encoded><![CDATA[十余位原FDA/CDE/千人共话创新制剂及改良型新药峰会]]></content:encoded><pubDate>Tue, 25 May 2021 17:30:37 +0800</pubDate></item><item><title>风云汇聚姑苏城：万名医药人共画中国CMC-China</title><link>https://mp.weixin.qq.com/s/fpKOmcMD17KTgLoFKyafeA</link><description></description><content:encoded><![CDATA[风云汇聚姑苏城：万名医药人共画中国CMC-China]]></content:encoded><pubDate>Tue, 25 May 2021 17:30:37 +0800</pubDate></item><item><title>阿达木单抗背后的技术：噬菌体展示技术</title><link>https://mp.weixin.qq.com/s/LLvDH9ovJlbipC7aVNJDRw</link><description></description><content:encoded><![CDATA[阿达木单抗背后的技术：噬菌体展示技术]]></content:encoded><pubDate>Tue, 25 May 2021 17:30:37 +0800</pubDate></item><item><title>License in模式大热，“云顶”奇迹背后的隐忧！</title><link>https://mp.weixin.qq.com/s/Ovoqhg2O5fsahD7nDzhaCg</link><description></description><content:encoded><![CDATA[License in模式大热，“云顶”奇迹背后的隐忧！]]></content:encoded><pubDate>Tue, 25 May 2021 17:30:37 +0800</pubDate></item><item><title>乘生物医药产业大势，这家大分子CDMO服务供应商在苏州快速成长</title><link>https://mp.weixin.qq.com/s/6xqSzTFbSCjbKmHLeMFt7g</link><description></description><content:encoded><![CDATA[乘生物医药产业大势，这家大分子CDMO服务供应商在苏州快速成长]]></content:encoded><pubDate>Mon, 24 May 2021 20:05:23 +0800</pubDate></item><item><title>晶泰智播｜晶型预测技术及多元化的应用</title><link>https://mp.weixin.qq.com/s/iFwkXseCYzwyjX_WVDoFcg</link><description></description><content:encoded><![CDATA[晶泰智播｜晶型预测技术及多元化的应用]]></content:encoded><pubDate>Mon, 24 May 2021 20:05:23 +0800</pubDate></item><item><title>风云汇聚姑苏城：万名医药人共画中国CMC-China</title><link>https://mp.weixin.qq.com/s/j-tdx5g9-VwhWuj1tcOOKQ</link><description></description><content:encoded><![CDATA[风云汇聚姑苏城：万名医药人共画中国CMC-China]]></content:encoded><pubDate>Mon, 24 May 2021 20:05:23 +0800</pubDate></item><item><title>重磅，小分子新锐同源康医药完成近4亿元人民币B+轮融资</title><link>https://mp.weixin.qq.com/s/G642Tk_h1Oo_hdWE0Ga0lA</link><description></description><content:encoded><![CDATA[重磅，小分子新锐同源康医药完成近4亿元人民币B+轮融资]]></content:encoded><pubDate>Mon, 24 May 2021 20:05:23 +0800</pubDate></item><item><title>ACGT China是什么？我为什么推荐给你</title><link>https://mp.weixin.qq.com/s/_4oZ1Vi5848SRlqiAikd_Q</link><description></description><content:encoded><![CDATA[ACGT China是什么？我为什么推荐给你]]></content:encoded><pubDate>Mon, 24 May 2021 20:05:23 +0800</pubDate></item><item><title>十余位原FDA/CDE/千人共话创新制剂及改良型新药峰会</title><link>https://mp.weixin.qq.com/s/eZTJlSAM89dWgtCFpqQRDg</link><description></description><content:encoded><![CDATA[十余位原FDA/CDE/千人共话创新制剂及改良型新药峰会]]></content:encoded><pubDate>Mon, 24 May 2021 20:05:23 +0800</pubDate></item><item><title>新锐|何大一教授创立的抗病毒抗体平台完成2400万美元A轮融资！</title><link>https://mp.weixin.qq.com/s/nnJwHyhuF9tc3FFlfT4xCQ</link><description></description><content:encoded><![CDATA[新锐|何大一教授创立的抗病毒抗体平台完成2400万美元A轮融资！]]></content:encoded><pubDate>Mon, 24 May 2021 20:05:23 +0800</pubDate></item><item><title>9200万美元E轮融资，开发靶向蛋白质降解管线和技术平台</title><link>https://mp.weixin.qq.com/s/mhH2PRJ4v5fiBRLqmO_qTw</link><description></description><content:encoded><![CDATA[9200万美元E轮融资，开发靶向蛋白质降解管线和技术平台]]></content:encoded><pubDate>Mon, 24 May 2021 20:05:23 +0800</pubDate></item><item><title>风云汇聚姑苏城：万名医药人共画中国CMC-China</title><link>https://mp.weixin.qq.com/s/3T68cuO5skX83Z-Ic1wLig</link><description></description><content:encoded><![CDATA[风云汇聚姑苏城：万名医药人共画中国CMC-China]]></content:encoded><pubDate>Sun, 23 May 2021 21:55:27 +0800</pubDate></item><item><title>科睿唯安直播预告：慧眼识局——透过数据选产品看市场</title><link>https://mp.weixin.qq.com/s/W7NTEWdWRXxLbkgvoKADOA</link><description></description><content:encoded><![CDATA[科睿唯安直播预告：慧眼识局——透过数据选产品看市场]]></content:encoded><pubDate>Sun, 23 May 2021 21:55:27 +0800</pubDate></item><item><title>邀请函丨改良型新药需要的特色技术平台</title><link>https://mp.weixin.qq.com/s/PCXO2gMKh2lKlLFsDob8hg</link><description></description><content:encoded><![CDATA[邀请函丨改良型新药需要的特色技术平台]]></content:encoded><pubDate>Sun, 23 May 2021 21:55:27 +0800</pubDate></item><item><title>十余位原FDA/CDE/千人共话创新制剂及改良型新药峰会</title><link>https://mp.weixin.qq.com/s/zpuc9jie2Pe07tU-mpXiKA</link><description></description><content:encoded><![CDATA[十余位原FDA/CDE/千人共话创新制剂及改良型新药峰会]]></content:encoded><pubDate>Sun, 23 May 2021 21:55:27 +0800</pubDate></item></channel></rss>